BNET Industries
Market Cap:$5.8M
Last Fiscal Year Sales:$37.6M
- Public
- US
Dow Jones Description
HemaCare Corporation ("HemaCare" or the "Company") provides the customized delivery of blood products and services. The Company collects, processes, purchases and distributes blood products to hospitals and research related organizations. The Company operates and manages donor centers and mobile donor vehicles to collect transfusable blood products from donors. In addition, the Company purchases blood products from other blood suppliers. The Company also provides blood related services, principally therapeutic apheresis procedures, stem cell collection and other blood treatments to patients with a variety of disorders. Blood related therapeutic services are usually provided to hospitals under contract as an outside purchased service. The Company has operated in Southern California since 1979. In 1998, the Company expanded operations to include portions of the eastern United States. In 2003, the Company reduced the number of geographic regions served as part of a restructuring plan to return the Company to profitability. From 2003 through 2006, the Company's earnings improved as a result of the successful implementation of this plan. In August 2006, the Company acquired Florida based Teragenix Corporation, subsequently renamed HemaCare BioScience, Inc. ("HemaBio"), which sourced, processed and distributed human biological specimens, manufactured quality control products and provided clinical trial management and support services. ...
CEO, General Manager, Transfusable Products
John DoumittNumber of Employees 180
Contact Information
15350 Sherman Way Ste 350
Van Nuys, California 91406
(818) 986-3883
Peer Companies
NAICS Code All Other Miscellaneous Ambulatory Health Care Services: 621999
Recent Events
-
HemaCare Announces Appointment of van der Wal as Vice President of Sales and Marketing
-
HemaCare names new vice president of sales and marketing
-
HemaCare Announces Appointment of van der Wal as Vice President of Sales and Marketing
-
HemaCare Reports Eighth Consecutive Profitable Quarter
-
HemaCare Reports Increase in Second Quarter Profit on Record
News & Analysis
Filter by
hemacare corp. - All News and Analysis
While HemaCare Corporation Release Quarter Results, Others Get Featured On The Food Market, Make Management Changes, Provide Support, Expand Order, and Sign Letter Of Intent.
- 2007-02-28
M2 PRESSWIRE-28 February 2007-SmallCapBull.com: While HemaCare Corporation Release Quarter Results, Others Get Featured On The Food Market, Make Management Changes, Provide Support, Expand Order, and Sign Letter Of IntentC1994-2007 M2 COMMUNICATIONS LTD RDATE:28022007 Dallas, Texas - SmallCapBull Pre-Market Updates for Wednesday...
HemaCare Corp. to Trade On OTC Bulletin Board
- 1998-11-02
LOS ANGELES--BUSINESS WIRE--Nov. 2, 1998--HemaCare Corp. announced today that, effective Oct. 30, 1998, its shares will no longer trade on the Nasdaq's SmallCap Market because the bid price for its shares has fallen below the $1.00 per share Nasdaq minimum listing maintenance requirement. The company's stock now qualifies to...
Hemacare Corp. Adopts Shareholders' Rights Plan and Announces 1997 Fourth-Quarter and Annual Results
- 1998-03-05
LOS ANGELES--BW HealthWire--March 5, 1998--HemaCare Corp. (Nasdaq:HEMA) announced the adoption of a shareholder rights plan to protect the interests of the company's shareholders. As a part of the rights plan, the board of directors declared a dividend of rights to purchase shares of a new series...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| John Doumitt | CEO, General Manager, Transfusable Products |
| Robert S. Chilton | Executive Vice, President, Chief, Financial Officer and Corporate Secretary |
| Joshua Levy | Co-Founder |
| Annabelle Baltierra | Hr Director |
| David Ciavarella | Medical Director |
| Jacquelyn Hedlund | Medical Director |
| Melanie Osby | Assistant Medical Director |
| Anna P Koo | |
| Beckman Coulter | |
| Linda Mondor | |
| Mary Ann Tourault | |
| Ronald O Gilcher | |
| Terry Van | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Julian L. Steffenhagen | Interim Chief Executive Officer, Chairman and Director |
| Steven B. Gerber | Chairman |
| Judi Irving | Board of Directors |
| Sheahan Teresa | Board of Directors |
| Teresa S Sligh | Board of Directors |
| Terry Van Der Tuuk | Board of Directors |
| Terry Van Der Tuuk | Vice Chairman, Graphic Technology |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | CEO, General Manager, Transfusable Products | Current |
| The Products | Executive Vice President | Current |
| The Products | General Manager | Current |
| HemaCare Corporation | Executive Vice President | Current |
| HemaCare Corporation | Board of Directors | Current |
| Activus Healthcare Solutions, Inc. | Vice President, Operations | Former |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Interim Chief Executive Officer, Chairman and Director | Current |
| HemaCare Corporation | Board of Directors | Former |
| University of Michigan | Master of Business Administration Degree | Former |
| University of Michigan | Bachelor of Science | Former |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Executive Vice, President, Chief, Financial Officer and Corporate Secretary | Current |
| HemaCare Corporation | Executive Vice President and CFO, General Manager, Therapeutic Services | Current |
| HemaCare Corporation | Board of Directors | Current |
| OrthAlliance, Inc. | Chief Financial Officer | Former |
| Therapeutic Services, Inc. | General Manager | Former |
| University of California, Los Angeles | Master of Business Administration | Former |
| University of California, Los Angeles | Bachelor of Arts Degrees | Former |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Co-Founder | Current |
| HemaCare Corporation | National Medical Director | Current |
| HemaCare Corporation | Board of Directors | Current |
| University of California, Los Angeles | Adjunct Associate Professor of Medicine | Former |
| Albert Einstein College | M.D. Degree | Former |
| Albert Einstein College of Medicine | Md | Former |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Hr Director | Current |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Medical Director | Current |
| Harvard Medical School | Instructor | Current |
| HemaCare Corporation | Board of Directors | Current |
| New York Blood Center, Inc. | Vice President | Former |
| University of California, Los Angeles | M.D. Degree | Former |
| Stanford University | Bachelor of Science, Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Medical Director | Current |
| HemaCare Corporation | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Assistant Medical Director | Current |
| Southern California Inc | Division Commissioner | Current |
| HemaCare Corporation | Board of Directors | Current |
| California State University | M.S. In Microbiology | Former |
| California State University | B.A. | Former |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Current |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Current | |
| Beckman Coulter, Inc. | Former | |
| University of Michigan | Master of Business Administration | Former |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Current | |
| University of Maine | B.A. in Technology | Former |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Current | |
| USC University Hospital, Inc. | Medical Director, Blood Bank | Former |
| USC School of Medicine | Assistant Professor of Pathology | Former |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Current |
| Organization | Position | Status |
|---|---|---|
| Wedbush Morgan Securities Inc. | Director of Research | Current |
| Tufts University School of Medicine | Board of Overseers | Current |
| HemaCare Corporation | Chairman | Current |
| Compensation Committees | Chair | Current |
| Quality Assurance | Board of Directors | Current |
| HemaCare Corporation | Director | Current |
| Itherx | Director | Current |
| Conor Medsystems, Inc. | Board of Directors | Current |
| Corporate Governance | Board of Directors | Current |
| Tufts University | MD | Former |
| University of California, Los Angeles | Masters of Business Administration Degree In Finance | Former |
| Brandeis University | Bachelor of Arts Degree In Psychology | Former |
| Tufts University | member | Former |
| HemaCare Corporation | member | Former |
| Organization | Position | Status |
|---|---|---|
| Physicians Management Group | Chief Executive Officer | Current |
| HemaCare Corporation | Board of Directors | Current |
| Health Net, Inc. | Chief Executive Officer | Former |
| HemaCare Corporation | Chief Executive Officer | Former |
| Health Net, Inc. | President | Former |
| PricewaterhouseCoopers | audit manager | Former |
| State University of New York at Binghamton | BS Degree In Management and Accounting | Former |
| State University of New York at Binghamton | CPA | Former |
| State University of New York at Binghamton | Bachelor of Science Degree In Management and Accounting | Former |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Board of Directors | Current |
Teresa S. Sligh, MD has been a director of the Company since May 2006. Since 2003, Dr. Sligh has been the President and Medical Director of Translational Research Group, Inc. and has served as the Chief Medical/Strategy Officer for Capital Technology Information Services, Inc. Dr. Sligh completed two years of post graduate medical training in Internal Medical at Presbyterian Hospital of Dallas, Texas, and received her M.D. degree at Texas A&M College of Medicine. She received her Bachelor of Science degree in biochemistry from the University of New Mexico. Dr. Sligh is the Chairwoman of the Quality Assurance Committee and a member of the Compensation Committee.
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Board of Directors | Current |
| Corporate Governance | Board of Directors | Current |
| The University of New Mexico | Bachelor of Science Degree In Biochemistry | Former |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Director | Current |
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Board of Directors | Current |
Terry Van Der Tuuk has been a director of the Company since May 2003. Since 1994, Mr. Van Der Tuuk has held the position of Vice Chairman of Graphic Technology, a barcode label company, which was listed on the American Stock Exchange and sold to Nitto-Denko Corporation in 1989. He is President of VanKan, Inc, a Kansas based venture capital firm which invests in privately held companies in the Midwest area. Mr. Van Der Tuuk served on several educational boards, including The Wharton School, University of Pennsylvania, and currently serves on the boards of several privately held companies. Mr. Van Der Tuuk received his Bachelor of Science degree from Michigan State University and his Masters of Business Administration degree from The Wharton School, University of Pennsylvania. Mr. Van Der Tuuk is a member of the Audit and Compensation Committees.
| Organization | Position | Status |
|---|---|---|
| HemaCare Corporation | Vice Chairman, Graphic Technology | Current |
| University of Pennsylvania | Board of Directors | Current |
| Graphic Technology, Inc | Vice Chairman | Current |
| Wharton Graduate School of the University of Pennsylvania | Board of Directors | Current |
| The American Stock Exchange LLC | Former | |
| Nitto Denko Corporation | Former | |
| Wharton Graduate School of the University of Pennsylvania | Masters of Business Administration Degree | Former |
| The Wharton School of the University of Pennsylvania | Masters of Business Administration Degree | Former |
| Michigan State University | Bachelor of Science Degree | Former |
Industry Transcripts by Seeking Alpha
-
Cantel Medical Corp. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 09, 2009about CMN
-
The Cooper Companies, Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about COO
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
Glass Door
Health Care Industry Companies
| Company | Employer Rating |
| Kaiser Permanente |  |
| Boston Scientific |  |
| WellPoint | |
| UnitedHealth Group |  |
| CIGNA | |
IndustryTop Rated
Presented by American Express